Satoshi Mashiko

1.8k total citations
27 papers, 1.4k citations indexed

About

Satoshi Mashiko is a scholar working on Endocrine and Autonomic Systems, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Satoshi Mashiko has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrine and Autonomic Systems, 12 papers in Cellular and Molecular Neuroscience and 7 papers in Physiology. Recurrent topics in Satoshi Mashiko's work include Regulation of Appetite and Obesity (17 papers), Neuropeptides and Animal Physiology (12 papers) and Biochemical Analysis and Sensing Techniques (6 papers). Satoshi Mashiko is often cited by papers focused on Regulation of Appetite and Obesity (17 papers), Neuropeptides and Animal Physiology (12 papers) and Biochemical Analysis and Sensing Techniques (6 papers). Satoshi Mashiko collaborates with scholars based in Japan and United States. Satoshi Mashiko's co-authors include Akio Kanatani, Akane Ishihara, Junko Itô, Hisashi Iwaasa, Akira Gomori, Ryuichi Moriya, Hiroko Matsushita, Takehiro Fukami, Hiromitsu Araki and Kazuhiko Takahashi and has published in prestigious journals such as Journal of Biological Chemistry, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Satoshi Mashiko

27 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Satoshi Mashiko Japan	18	812	464	425	404	375	27	1.4k
C. Netti Italy	22	647 0.8×	610 1.3×	531 1.2×	410 1.0×	390 1.0×	73	1.6k
Blanka Železná Czechia	27	618 0.8×	636 1.4×	493 1.2×	304 0.8×	800 2.1×	111	2.0k
Derek J. Zimmer United States	19	686 0.8×	459 1.0×	287 0.7×	268 0.7×	635 1.7×	19	1.5k
Heather Halem United States	16	723 0.9×	829 1.8×	218 0.5×	535 1.3×	379 1.0×	29	1.6k
Garron T. Dodd Australia	22	623 0.8×	671 1.4×	154 0.4×	256 0.6×	596 1.6×	32	1.9k
Kyoko Miyasaka Japan	26	553 0.7×	422 0.9×	914 2.2×	255 0.6×	578 1.5×	149	2.2k
Oksana Palyha United States	16	1.8k 2.2×	981 2.1×	413 1.0×	1.2k 3.1×	509 1.4×	23	2.5k
Omar Al–Massadi Spain	26	806 1.0×	837 1.8×	117 0.3×	412 1.0×	360 1.0×	58	1.7k
Drew T. Weingarth United States	8	825 1.0×	561 1.2×	120 0.3×	536 1.3×	117 0.3×	8	1.1k
Lorraine Ghibaudi United States	14	614 0.8×	575 1.2×	194 0.5×	315 0.8×	184 0.5×	14	1.2k

Countries citing papers authored by Satoshi Mashiko

Since Specialization

Citations

This map shows the geographic impact of Satoshi Mashiko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Mashiko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Mashiko more than expected).

Fields of papers citing papers by Satoshi Mashiko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Mashiko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Mashiko. The network helps show where Satoshi Mashiko may publish in the future.

Co-authorship network of co-authors of Satoshi Mashiko

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Mashiko. A scholar is included among the top collaborators of Satoshi Mashiko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Mashiko. Satoshi Mashiko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Moriya, Ryuichi, Satoshi Mashiko, Akane Ishihara, et al.. (2009). Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice. Peptides. 30(7). 1318–1322. 15 indexed citations

2.

Mashiko, Satoshi, Ryuichi Moriya, Akane Ishihara, et al.. (2009). Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis. European Journal of Pharmacology. 615(1-3). 113–117. 39 indexed citations

3.

Ito, Masahiko, Akane Ishihara, Akira Gomori, et al.. (2009). Melanin-concentrating hormone 1-receptor antagonist suppresses body weight gain correlated with high receptor occupancy levels in diet-induced obesity mice. European Journal of Pharmacology. 624(1-3). 77–83. 18 indexed citations

4.

Sato, Nagaaki, Yoshio Ogino, Satoshi Mashiko, & Makoto Ando. (2009). Modulation of neuropeptide Y receptors for the treatment of obesity. Expert Opinion on Therapeutic Patents. 19(10). 1401–1415. 50 indexed citations

5.

Moriya, Ryuichi, Takashi Shirakura, Junko Itô, Satoshi Mashiko, & Toru Seo. (2009). Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice. American Journal of Physiology-Endocrinology and Metabolism. 297(6). E1358–E1365. 135 indexed citations

6.

Mashiko, Satoshi, Akane Ishihara, Hisashi Iwaasa, et al.. (2008). Effects of a Novel Y5 Antagonist in Obese Mice: Combination With Food Restriction or Sibutramine. Obesity. 16(7). 1510–1515. 24 indexed citations

7.

Gomori, Akira, Akane Ishihara, Makoto Ito, et al.. (2007). Blockade of MCH1 receptor signalling ameliorates obesity and related hepatic steatosis in ovariectomized mice. British Journal of Pharmacology. 151(6). 900–908. 26 indexed citations

8.

Mashiko, Satoshi, Akane Ishihara, Hisashi Iwaasa, et al.. (2006). A Pair-Feeding Study Reveals That a Y5 Antagonist Causes Weight Loss in Diet-Induced Obese Mice by Modulating Food Intake and Energy Expenditure. Molecular Pharmacology. 71(2). 602–608. 37 indexed citations

9.

Mashiko, Satoshi, Akane Ishihara, Akira Gomori, et al.. (2005). Antiobesity Effect of a Melanin-Concentrating Hormone 1 Receptor Antagonist in Diet-Induced Obese Mice. Endocrinology. 146(7). 3080–3086. 58 indexed citations

10.

Takahashi, Kazuhiko, Shinji Mizuarai, Hiromitsu Araki, et al.. (2003). Adiposity Elevates Plasma MCP-1 Levels Leading to the Increased CD11b-positive Monocytes in Mice. Journal of Biological Chemistry. 278(47). 46654–46660. 269 indexed citations

11.

Mashiko, Satoshi, Akane Ishihara, Hisashi Iwaasa, et al.. (2003). Characterization of Neuropeptide Y (NPY) Y5 Receptor-Mediated Obesity in Mice: Chronic Intracerebroventricular Infusion ofd-Trp³⁴NPY. Endocrinology. 144(5). 1793–1801. 51 indexed citations

12.

Ito, Masahiko, Akira Gomori, Akane Ishihara, et al.. (2003). Characterization of MCH-mediated obesity in mice. American Journal of Physiology-Endocrinology and Metabolism. 284(5). E940–E945. 137 indexed citations

13.

Ishihara, Akane, Akio Kanatani, Megumu Okada, et al.. (2002). Blockade of body weight gain and plasma corticosterone levels in Zucker fatty rats using an orally active neuropeptide Y Y1 antagonist. British Journal of Pharmacology. 136(3). 341–346. 25 indexed citations

14.

Kanatani, Akio, M. Hata, Satoshi Mashiko, et al.. (2001). A Typical Y1 Receptor Regulates Feeding Behaviors: Effects of a Potent and Selective Y1 Antagonist, J-115814. Molecular Pharmacology. 59(3). 501–505. 79 indexed citations

15.

Kanatani, Akio, M. Hata, Satoshi Mashiko, et al.. (2001). A Typical Y1 Receptor Regulates Feeding Behaviors: Effects of a Potent and Selective Y1 Antagonist, J-115814. Molecular Pharmacology. 59(3). 501–505. 3 indexed citations

16.

Hirose, Hiroyasu, Satoshi Mashiko, Toshifumi Kimura, et al.. (2000). Antithrombotic Activity of NSP-513, a Novel Selective Phosphodiesterase 3 Inhibitor, on Femoral Arterial Thrombosis Induced by Physical Stenosis and Electrical Current: Comparison of Antithrombotic and Hemodynamic Effects. Journal of Cardiovascular Pharmacology. 35(4). 586–594. 8 indexed citations

17.

Tomita, Takako, et al.. (1995). BLOOD PRESSURE‐RELATED CHANGES OF ENDOTHELIUM‐DEPENDENT RELAXATION IN THE AORTA FROM SHRSP AT DEVELOPMENTAL AGES OF HYPERTENSION. Clinical and Experimental Pharmacology and Physiology. 22(s1). S139–41. 11 indexed citations

18.

Mashiko, Satoshi, et al.. (1995). CORRELATION ANALYSIS OF BLOOD PRESSURE AND PLATELET AGGREGATION/VASCULAR REACTIVITY IN SHRSP, WKY, F1 AND BACKCROSS GENERATIONS. Clinical and Experimental Pharmacology and Physiology. 22(s1). S107–8. 3 indexed citations

19.

Onda, Takeshi, et al.. (1994). ENHANCEMENT OF ENDOTHELIUM‐DEPENDENT RELAXATION IN THE AORTA FROM STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS AT DEVELOPMENTAL STAGES OF HYPERTENSION. Clinical and Experimental Pharmacology and Physiology. 21(11). 857–863. 22 indexed citations

20.

Onda, Takeshi, et al.. (1994). Enhancement of Endothelium-Dependent Relaxation (EDR) in the Aorta from SHRSP at Developmental Ages of Hypertension, and Effects of Hypotensive Treatment on EDR in SHRSP. Japanese Heart Journal. 35(4). 520–520. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact